UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2023	$ 36	$ 593	$ (10,658)	$ 138,341	$ 128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options	$ 0	96	0	0	96
Common stock issued upon exercise of employee stock options, shares	2
Common stock received and retired upon exercise of stock options	$ 0	0	0	0	0
Stock option compensation expense	0	79	0	0	79
Common stock purchased and retired	$ 0	(769)	0	(2,221)	(2,990)
Common stock purchased and retired, shares	(43)
Foreign currency translation adjustment	$ 0	0	(631)	0	(631)
Common stock dividends	0	0	0	(1,081)	(1,081)
Net income	0	0	0	3,956	3,956
Equity Balance, value at Mar. 31, 2024	$ 36	0	(11,289)	138,995	127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Equity Balance, value at Dec. 31, 2024	$ 33	0	(11,908)	129,302	117,427
Equity Balance, shares at Dec. 31, 2024	3,335
Common stock issued upon exercise of employee stock options	$ 0	0	0	0	0
Common stock issued upon exercise of employee stock options, shares	0
Common stock received and retired upon exercise of stock options	$ 0	0	0	0	0
Common stock received and retired upon exercise of stock options, shares	0
Stock option compensation expense	$ 0	82	0	0	82
Common stock purchased and retired	$ (1)	(82)	0	(3,138)	(3,221)
Common stock purchased and retired, shares	(54)
Foreign currency translation adjustment	$ 0	0	718	0	718
Common stock dividends	0	0	0	(1,001)	(1,001)
Net income	0	0	0	3,041	3,041
Equity Balance, value at Mar. 31, 2025	$ 33	$ 0	$ (11,190)	$ 128,204	$ 117,047
Equity Balance, shares at Mar. 31, 2025	3,281